WIN-Partners Co (TSE:3183) Dividends Received

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:3183 WIN-Partners Co Ltd TSE:3183
67 GF Score
Price 円1,308.00
GF Value 円1,528.85
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is WIN-Partners Co Dividends Received?

Dividends Received only applicable to companies reporting Cash Flow from Operations in direct method.

TSE:3183
67GF Score
WIN-Partners Co Ltd TSE:3183
Dividends Received is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is WIN-Partners Co (TSE:3183) Overvalued in 2026?

Based on GuruFocus' analysis, WIN-Partners Co stock appears to be undervalued. The current stock price of 円1,308.00 is trading 14.4% below its estimated GF Value™ of 円1,528.85. GuruFocus considers WIN-Partners Co to be Modestly Undervalued.

Key valuation signals for TSE:3183:

  • Dividends Received:
  • GF Value™: 円1,528.85 vs. price of 円1,308.00 (14.4% below fair value)
  • GF Score™: 67/100 with 3 warning signs

No single metric tells the full story. See the TSE:3183 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


WIN-Partners Co Business Description

Address 2-2-1 Kyobashi, Chuoku, 21st Floor, Kyobashi Edogrand, Tokyo, JPN, 104-0031
WIN-Partners Co Ltd is engaged in the healthcare sector. The company provides medical devices to Japan's medical institutions. Its products offerings are Cardiovascular device, Insulin Pump, X-ray Angio System, Carotid Artery Stent, Stent Graft, among others. The company operates only in one segment which is the medical equipment sales business.
67GF Score

Get the complete analysis for TSE:3183

Dividends Received is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円1,308.00
Price
円1,528.85
GF Value